Workshop Series: Michael Willenborg
Abstract: The workshop I am preparing deals with "A survey of IPO-related accounting research", which will cover IPO papers published in the top accounting journals over the past 25 years. The primary streams of this literature pertain to IPO-related research in: auditing; earnings management; valuation; and disclosure. Time permitting, I also hope to weave into the workshop discussion current developments in the IPO finance literature and how this recent literature may relate to accounting and auditing. Join our staff, students and alumni attending workshops presented by visiting academics on their area of research expertise.
Professor Willenborg is the Andersen Faculty Fellow (since 2000) and a School of Business Ackerman Scholar (since 2001) at the University of Connecticut. He has published research in Contemporary Accounting Research, Journal of Accounting and Economics, Journal of Accounting Research, Journal of Financial Economics, the Journal of Risk and Insurance, and The Accounting Review. He has received the School of Business Best Article Awards for 1999, 2000, 2004 and 2007. In 2000, he received the American Tax Association's Outstanding Manuscript Award. He received the Beta Alpha Psi Professor of the Year Award in both 1998 and 1999, the School of Business Undergraduate Professor of the Year for 2000, the School of Business Graduate Professor of the Year for 2002 and the MBA Core Professor of the Year Award for 2001-2004 and 2006-2008 for teaching excellence. Dr. Willenborg's research interests include accounting, auditing and finance issues associated with new offerings of equity securities. He is currently Associate Editor for Contemporary Accounting Research and previously was a member of the Editorial Advisory and Review Board of The Accounting Review. In 2004, he received the School of Business Outstanding Service Award.
Professor Willenborg's most recent publications focus on rules and discretion in audit standards, litigation risk and audit in IPOs, and use of proceeds information and endogeneity issues in relation to disclosures relevant to pricing IPOs.